Paul M. Roman, PhD, Distinguished Research Professor of Sociology, has been at the University of Georgia since 1986. He received a Ph.D. in Sociology from Cornell University in 1968. Dr. Roman's most recent work examines organizational change and adaptation in national samples of 900 public and private substance abuse treatment organizations; diffusion and adoption of innovations by substance abuse treatment organizations; organization and management in a national sample of 400 therapeutic communities; management of substance dependence in the workplace, macro and micro dynamics of the treatment of alcoholism, implementation of policies in workplaces. READ MORE...
Dennis Daley, PhD
Dr. Daley is Professor of Psychiatry at the University of Pittsburgh School of Medicine and served for 14 years as Chief of Addiction Medicine Services (AMS) at Western Psychiatric Institute and Clinic in the Department of Psychiatry. He holds an adjunct position as Professor of Social Work at the University of Pittsburgh. He assumed a major role in developing and managing a large continuum of prevention, intervention and treatment services in psychiatric hospitals, community residential settings, medical hospitals, ambulatory settings and specialty settings. Dr. Daley and colleagues developed one of the first integrated treatment programs in the United States for patients with substance use and psychiatric disorders. He was the first author on one the first treatment books for front line clinicians that focused on co-occurring disorders, and first author on one of NIDA’s therapy manuals for drug abuse.
Michael T. Flaherty, PhD
Dr. Flaherty is a clinical psychologist with more than 30 years experience in the prevention, intervention, treatment, research and policy development related to substance use, addiction,and recovery. Seeking to align science, service, and policy he founded the Institute for Research, Education and Training in the Addictions (IRETA) in 1999 and become the Principle Investigator of its HHS/SAMHSA/CSAT funded Northeast ATTC. Dr. Flaherty previously was the Vice President of the St. Francis Health System in Pittsburgh and director of its Institute for Psychiatry and Addiction Services, then the largest hospital and community based behavioral health system in Pennsylvania. He has authored and overseen over 20 federal and foundational grants, and more than 40 articles and monographs on addiction-related topics.
Heather Gotham, PhD
Heather Gotham, Ph.D., is a Research Associate Professor and Senior Manager of Evaluation at the Mid-America Addiction Technology Transfer Center (Mid-America ATTC) at the University of Missouri-Kansas City. She is a licensed psychologist. Gotham’s research focuses on implementation of evidence-based substance abuse and mental health treatments for adolescents and adults, including the longitudinal course of and factors affecting implementation. She serves as co-director of evaluation for Missouri’s COSIG – state infrastructure grant for co-occurring substance use and mental illness as well as for a multi-site evaluation of a privately-funded co-occurring disorders initiative in Missouri. Gotham assisted in the development of several measures of capability to provide services to clients with co-occurring disorders. She has served as co-investigator and evaluator on federally-funded substance abuse prevention and treatment grants. She has also provided technical assistance to several states and individual treatment providers to implement evidence-based practices and assessments. Gotham is a peer reviewer for several journals, and a grant reviewer for NIH and SAMHSA. She is a member of the American Psychological Association, the College on Problems of Drug Dependence, and the Research Society on Alcoholism.
Louise Haynes, MSW
Louise Haynes is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina and is Director of Research for the Lexington Richland Alcohol and Drug Abuse Council. She has worked with the NIDA Clinical Trials Network for more than 12 years. In addition to her research experience, Ms Haynes has worked in both clinical and administrative roles in South Carolina. She was Director of Women’s Services for the Single State Authority (DAODAS) and Director of Morris Village, a 150 bed, publically-supported residential treatment program.
Ron Jackson, MSW, LICSW
Ron Jackson, M.S.W., LICSW, is the recently retired Executive Director of Evergreen Treatment Services (ETS), a private non-profit organization, in Seattle, Washington, that provides outpatient opioid treatment to over 1500 patients in clinics in Seattle and Olympia, WA and street-based case management services for homeless addicts (REACH Program) in Seattle. He served for 10 years as a co-principal investigator for the Washington Node of NIDA’s Clinical Trials Network and is an Affiliate Professor at the University of Washington’s School of Social Work where he teaches course about addiction and counseling skills used in the treatment of addiction. He also provides consultation to organizations on evidenced-based behavioral treatment interventions. He has worked in the field of addiction treatment since 1972.
Dr. Jeffrey Junig, MD, PhD
Dr. Jeffrey Junig earned a PhD in Neuroscience at the Center for Brain Research, and a medical degree at the University of Rochester School of Medicine and Dentistry. Following his work as an anesthesiologist and pain treatment physician at St. Agnes Hospital, serving as Chief of Anesthesia during most of that time, Dr. Junig entered residency in psychiatry and behavioral medicine at the Medical College of Wisconsin, earning Board Certification by the American Board of Psychiatry and Neurology in 2008. Dr. Junig teaches residents and medical students at the Medical College of Wisconsin and maintains a psychiatric practice in Fond du Lac, Wisconsin.
Lee Ann Kaskutas, PhD
Lee Ann Kaskutas is a senior scientist at PHI's Alcohol Research Group (ARG) and the director of training for its National Alcohol Research Center. Since starting at ARG in 1990, Kaskutas' professional interest has been to find solutions to alcohol-related problems that do not require professionally trained individuals for implementation. Dr. Kaskutas has conducted two NIH-funded clinical trials that compared the costs and outcomes of clinical and social model treatment programs. She is studying the long-term Alcoholics Anonymous (AA) "careers" of treated and untreated substance abusers; and she co-designed an intervention to open dialogue with pregnant women regarding how much they drink. Read about her projects and publications.
Hannah Knudsen, PhD
Hannah K. Knudsen is an Assistant Professor in the Department of Behavioral Science and a faculty member of the Center on Drug and Alcohol Research at the University of Kentucky. Her research focuses on addiction treatment organizations and the counseling workforce. Much of her research has considered how organizational and environmental factors are related to the delivery of health services in addiction treatment organizations. Through support from the Robert Wood Johnson Foundation’s Substance Abuse Policy Research Project (SAPRP), she recently completed a project that examined the quality of treatment services available in programs that serve adolescents with substance use disorders. Currently, she is the principal investigator on two research projects. The first project, newly funded by SAPRP, is examining organizational and state policy barriers to the adoption of pharmacotherapies in publicly-financed substance abuse treatment centers. The second project, funded by the National Institute on Drug Abuse, is examining the adoption and implementation of the Public Health Service’s clinical practice guidelines for smoking cessation in the context of addiction treatment as well as the attitudes of counselors toward smoking cessation. In addition to her work on innovation adoption, she has researched issues related to the addiction workforce. She has published several studies of counselor burnout and turnover in which she has examined how managerial practices, experiences with clinical research, and clinical supervision are associated with these outcomes. In addition, she has examined counselors’ attitudes toward evidence-based treatment practices, such as the use of buprenorphine for treating opiate dependence.
Dr. Laudet is the founder and Director of the Center for the Study of Addictions and Recovery at the National Development and Research Institutes, Inc. (NDRI) and also served as Deputy Director of NDRI's Institute for Treatment and Services Research. View her complete bio.
Dennis McCarty, PhD
Dennis McCarty, PhD, is a Professor in the Department of Public Health & Preventive Medicine at Oregon Health & Science University. He collaborates with policy makers in state and federal government and with community based programs to examine the organization, financing, and quality of publicly funded prevention and treatment services for alcohol and drug disorders. He is the Principal Investigator for the Oregon/Hawaii Node of the National Drug Abuse Treatment Clinical Trials Network (funded by the National Institute on Drug Abuse) and the national evaluation for the Network for the Improvement of Addiction Treatment. Between 1989 and 1995, Dr. McCarty directed the Massachusetts Bureau of Substance Abuse Services for the Massachusetts Department of Public Health. His PhD in Social Psychology is from the University of Kentucky.
Steve Martino, Ph.D.
Dr. Martino has specific expertise in research concerning the efficacy and effectiveness of Motivational Interviewing (MI). He has applied MI to patients with co-occurring substance use and major psychiatric disorders and has studied the effectiveness of MI when implemented in community treatment program settings. Within this work, Dr. Martino has developed adherence and competence rating systems to document clinician proficiency in rendering MI and has modified these materials for use as clinical supervision tools among substance abuse treatment providers. In addition, Dr. Martino is conducting evidence-based psychotherapy dissemination research in which he is studying different strategies for training clinicians in MI. Similarly, he collaborates on several cognitive behavioral clinician training studies. Finally, Dr. Martino is interested in curriculum development within the medical school and how to train students and professionals in behavior change counseling strategies.
Elizabeth Wells, PhD
Dr. Wells’ research interests include integrated approaches to prevention and treatment of substance use disorders, etiological theories and prevention of adolescent health risk behavior, and prevention of HIV risk behavior in adolescents and adults. Dr. Wells earned her BA in Psychology from New College in 1974 and her PhD in clinical psychology from the University of Washington in 1984 and is a Research Professor at the University of Washington’s School of Social Work. In this role, and through her affiliation with the University’s Alcohol and Drug Abuse Institute, Dr. Wells currently serves as a co-investigator for the Pacific Northwest Node of the National Drug Abuse Treatment Clinical Trials Network (CTN). As a member and former chair of the network’s Research Utilization Committee, Dr. Wells has an ongoing interest in implementation of evidence-based practices in community treatment. For the past 30 years, she has worked in collaboration with community treatment programs evaluating interventions for a variety of substance use disorders. Her studies have focused on a range of interventions, including Cognitive Behavioral Treatment, Motivational Enhancement Therapy, 12-Step Facilitation, and acupuncture. Dr. Wells has been a mentor to social work graduate students for more than 20 years and has chaired and served on doctoral committees in the School of Social Work and other units. She has also served as a mentor in the Pre-doctoral Research Training Program for Prevention Research in Mental Health Problems and Disorders at the University of Washington.
Greg is a person in long-term recovery from addiction to alcohol and other drugs since age seventeen. He is a health policy advocate, and award-winning documentary filmmaker who specializes in the creation of compelling and purposeful content. "The Anonymous People" is Greg’s first independent feature-length film, bringing lasting solutions to the screen for one of America’s top health problems.